Effects of the combination of hyperbaric oxygen and 5-fluorouracil on proliferation and metastasis of human nasopharyngeal carcinoma CNE-2Z cells

Undersea and Hyperbaric Medicine

Volumn 37, Issue 3, 2010, Pages 141-150

  Zheng Rong, Peng ^a   Wei Hong, Zhong ^a   Juan, Liu ^a   Ping Tian, Xiao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL; GELATINASE B; VASCULOTROPIN A;

ARTICLE; CANCER INVASION; CELL MIGRATION; CELL MOTION; CELL PROLIFERATION; DRUG EFFECT; HUMAN; HYPERBARIC OXYGEN; IC 50; METABOLISM; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NASOPHARYNX TUMOR; PATHOLOGY; TIME; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CELL MOVEMENT; CELL PROLIFERATION; COMBINED MODALITY THERAPY; FLUOROURACIL; HUMANS; HYPERBARIC OXYGENATION; INHIBITORY CONCENTRATION 50; MATRIX METALLOPROTEINASE 9; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77954302487     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Zeng Q, Guo X, Li NW, et al. Clinical characteristics and prognosis of aged nasopharyngeal carcinoma patients: a report of 313 cases. Ai Zheng. 2008 Mar; 27 (3):289-94.
2. Kinoshita Y, Kohshi K, Kunugita N, et al. Preservation of tumour oxygen after hyperbaric oxygenation monitored by magnetic resonance imaging. Br J Cancer. 2000, 82 (1):88-92.
3. Kunugita N, Kohshi K, Kinoshita Y et al. Radiotherapy after hyperbaric oxygenation improves radioresponse in experimental tumor models. Cancer Lett. 2001 Mar. 26; 164 (2):149-54.
4. Kohshi K, Yamamoto H, Nakahara A, et al. Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent highgrade gliomas. J Neurooncol. 2007 May; 82 (3):297-303. Epub 2006 Nov. 22.
5. Lin JC, Jan J S, Hsu CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol, 2003, 21 (4):631-637.
6. Schönmeyr BH, Wong AK, Reid VJ, et al. The effect of hyperbaric oxygen treatment on squamous cell cancer growth and tumor hypoxia. Ann Plast Surg. 2008 Jan; 60 (1):81-88.
7. Chu ST, Wu PH, Hou YY, et al. Primary tumor volume of nasopharyngeal carcinoma: significance for recurrence and survival. J Chin Med Assoc. 2008, 71 (9):461-466.
8. Plotkine E, Coscas R, Guigui P, et al. Digital metastasis of nasopharyngeal carcinoma: a surgical trap. Case report and literature review. Chir Main. 2008, 27 (4):187-190.
9. Qin L, Zhang X, Zhang L, et al. Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 2008, 371 (3):531-535.
10. Stuhr LE, Iversen VV, Straume O, et al. Hyperbaric oxygen alone or combined with 5-FU attenuates growth of DMBA-induced rat mammary tumors. Cancer Lett, 2004 Jul. 8; 210 (1):35-40.
11. Narozny W, Sicko Z, Przewozny T et al. Hyperbaric oxygen therapy as a method of treatment of laryngeal and pharyngeal radionecrosis. Otolaryngol Pol, 2001;55(1):57-60.
12. Chiantore MV, Vannucchi S, Mangino G, et al. Senescence and cell death pathways and their role in cancer therapeutic outcome. Curr Med Chem. 2009, 16 (3):287-300.
13. Feldmeier, Carl U, Hartmann K, et al. Hyperbaric oxygen: does it promote growth or recurrence of malignancy? Undersea Hyperb Med, 2003 Spring; 30 (1):1-18.
14. McDonald K, Bradfield J, Kinsella J, et al. Effect of hyperbaric oxygenation on existing oral mucosal carcinoma. Laryngoscope, 1996 Aug; 106 (8):957-9.
15. Marasà L, Marasa S, Sciancalepore G. Collagen IV, laminin, fibronectin, vitronectin. Comparative study in basal cell carcinoma. Correlation between basement membrane molecules expression and invasive potential. G Ital Dermatol Venereol. 2008, 143 (3):169-173.
16. Zeitoun G, Mourra N, Blanché-Koch H, et al. Genomic profile of colon cancer metastases. Anticancer Res. 2008, 28 (6 A): 3609-3612.
17. Lin JC, Jan JS, Chen KY, et al. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma. Head Neck. 2003, 25 (6):438-450.
18. Kawasoe Y, Yokouchi M, Ueno Y, et al. Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of osteosarcoma. Oncol Rep. 2009, 22 (5):1045-1050.
19. Maeta H, Ohgi S, Terada T, et al. Protein expression of matrix metalloproteinase 2 and 9 and tissue carcinomas. Virchows Arch, 2001, 438:121-128.
20. Pal S, Datta K, Mukhopadhyay D. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPFV VEGF) expression in mammary carcinoma. Cancer, 2001, 61 (18):6952-6957.
21. Horikawa T, Yoshizaki T, Sheen TS, et al. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer, 2000, 89 (4):715-723.
22. Wakisaka N, Wen QH, Yoshizaki T, et al. Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma. Laryngoscope, 1999, 109 (5):810-814.
23. Shi Y, Lee CS, Wu J, et al. Effects of hyperbaric oxygen exposure on experimental head and neck tumor growth, oxygenation, and vasculature. Head Neck. 2005, 27 (5):362-369.
24. Feldmeier, Carl U, Hartmann K, et al. Hyperbaric oxygen: does it promote growth or recurrence of malignancy? Undersea Hyperb Med, 2003, 30 (1):1-18.
25. Ooyama A, Oka T, Zhao HY, et al. Anti-angiogenic effect of 5-Fluorouracil- based drugs against human colon cancer xenografts. Cancer Lett. 2008, 267 (1):26-36.